Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-3-8
pubmed:abstractText
The aim of this study was to further investigate dendritic cell (DC)-based immunotherapy for malignant glioma to improve its therapeutic efficacy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-3085
pubmed:author
pubmed:issnType
Print
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
474-81
pubmed:dateRevised
2006-4-21
pubmed:meshHeading
pubmed-meshheading:11235953-Animals, pubmed-meshheading:11235953-Apoptosis, pubmed-meshheading:11235953-Bone Marrow Cells, pubmed-meshheading:11235953-Brain Neoplasms, pubmed-meshheading:11235953-CD8-Positive T-Lymphocytes, pubmed-meshheading:11235953-DNA, Complementary, pubmed-meshheading:11235953-Dendritic Cells, pubmed-meshheading:11235953-Gene Therapy, pubmed-meshheading:11235953-Genetic Vectors, pubmed-meshheading:11235953-Glioma, pubmed-meshheading:11235953-Immunization, pubmed-meshheading:11235953-Immunotherapy, pubmed-meshheading:11235953-Melanoma, pubmed-meshheading:11235953-Mice, pubmed-meshheading:11235953-Mice, Inbred C57BL, pubmed-meshheading:11235953-Semliki forest virus, pubmed-meshheading:11235953-Survival Rate, pubmed-meshheading:11235953-Transfection, pubmed-meshheading:11235953-Tumor Cells, Cultured
pubmed:year
2001
pubmed:articleTitle
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
pubmed:affiliation
Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. ryaman@pop11.odn.ne.jp
pubmed:publicationType
Journal Article